Robert Iannone

Insider Reports History

Entity
Individual
Location
300 The American Way, Morris Plains, NJ
Signature
/s/ Adi Osovsky, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Robert Iannone:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Jazz Pharmaceuticals plc EVP, Global Head of R&D Ordinary Shares 62.2K $7.31M $117.53 Mar 5, 2024 Direct
iTeos Therapeutics, Inc. Director Stock Option (Right to Buy) 24.2K Jun 11, 2024 Direct
Jounce Therapeutics, Inc. Director Stock Option (Right to Buy) 0 May 3, 2023 Direct

Insider Reports Filed by Robert Iannone

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ITOS iTeos Therapeutics, Inc. Jun 11, 2024 1 $0 4 Jun 13, 2024 Director
JAZZ Jazz Pharmaceuticals plc Mar 5, 2024 1 -$505K 4 Mar 7, 2024 EVP, Global Head of R&D
JAZZ Jazz Pharmaceuticals plc Mar 1, 2024 1 $0 4 Mar 5, 2024 EVP, Global Head of R&D
JAZZ Jazz Pharmaceuticals plc Jan 17, 2024 2 -$206K 4 Jan 19, 2024 EVP, Global Head of R&D
ITOS iTeos Therapeutics, Inc. Jun 13, 2023 1 $0 4 Jun 15, 2023 Director
JAZZ Jazz Pharmaceuticals plc Jun 5, 2023 1 -$170K 4 Jun 7, 2023 EVP, Global Head of Research a
JNCE Jounce Therapeutics, Inc. May 3, 2023 4 $0 4 May 4, 2023 Director
JAZZ Jazz Pharmaceuticals plc Mar 3, 2023 2 -$325K 4 Mar 7, 2023 EVP, Global Head of Research a
JAZZ Jazz Pharmaceuticals plc Dec 9, 2022 1 -$279K 4 Dec 13, 2022 EVP, Global Head of R&D
JNCE Jounce Therapeutics, Inc. Jun 24, 2022 1 $0 4 Jun 28, 2022 Director
ITOS iTeos Therapeutics, Inc. Jun 9, 2022 1 $0 4 Jun 10, 2022 Director
JAZZ Jazz Pharmaceuticals plc Jun 6, 2022 1 -$193K 4 Jun 8, 2022 EVP, Global Head of R&D
JAZZ Jazz Pharmaceuticals plc Mar 3, 2022 2 -$204K 4 Mar 9, 2022 EVP, Global Head of R&D and Ch
JNCE Jounce Therapeutics, Inc. Jun 18, 2021 1 $0 4 Jun 22, 2021 Director
ITOS iTeos Therapeutics, Inc. Jun 17, 2021 1 $0 4 Jun 21, 2021 Director
JAZZ Jazz Pharmaceuticals plc Jun 5, 2021 1 -$213K 4 Jun 9, 2021 EVP R&D, Chief Medical Officer